Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2013-06-25 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
CONNECTED TRANSACTION - ACQUISITION OF 100% EQUITY INTEREST IN CSPC BAIKE (YANTAI) BIOPHARMACEUTICAL CO., LTD. AND 45% EQUITY INTEREST IN CSPC HUASHENG PHARMACEUTICAL CO., LTD.
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding connected transactions involving the acquisition of equity interests in two companies by CSPC Pharmaceutical Group Limited. It details the terms, considerations, and conditions of these acquisitions, including references to the Listing Rules and connected persons. The content focuses on the announcement of these acquisitions and their implications under regulatory rules, rather than being a full financial report or detailed management discussion. The document is lengthy (15,000 characters) and contains detailed transaction information, but it is structured as an announcement of corporate actions related to capital transactions. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as acquisitions of equity interests. Therefore, the appropriate classification is CAP with high confidence.
2013-06-25 English
Adjustment to Conversion Price of Convertible Bonds Due 2017
Capital/Financing Update Classification · 95% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding an adjustment to the conversion price of its convertible bonds due to a dividend payment. It references prior circulars and annual results announcements but does not contain financial statements or detailed financial data itself. The content focuses on a specific capital structure change related to convertible bonds and dividend adjustments, which is typical of a capital/financing update. The document length is 4543 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2013-06-14 English
List of Directors and their Role and Function
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors, their roles, and committee memberships. It focuses on governance structure and board composition without financial data or report content. This matches the description of Board/Management Information (MANG), which covers announcements of changes or details about the company's board or senior management. The document is short and does not contain financial statements or other report types. Therefore, it is classified as MANG with high confidence.
2013-06-10 English
APPOINTMENT OF EXECUTIVE DIRECTOR
Board/Management Information Classification · 100% confidence The document is an announcement from the Board of Directors regarding the appointment of an executive director, Mr. WANG Jinxu. It details his background, terms of appointment, remuneration, and share interests. There is no financial data, report, or regulatory filing referenced beyond the appointment itself. The document is short (3382 characters) and focuses solely on management change. According to the definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG).
2013-06-10 English
DISPOSAL OF A WHOLLY-OWNED SUBSIDIARY
Capital/Financing Update Classification · 95% confidence The document is an announcement by CSPC Pharmaceutical Group Limited regarding a discloseable transaction involving the disposal of a wholly-owned subsidiary. It details the terms of the sale, financial information of the subsidiary, consideration, guarantees, and reasons for the disposal. The document is a formal announcement of a corporate transaction rather than a financial report or earnings release. It does not contain comprehensive financial statements or quarterly results but focuses on the transaction details and regulatory compliance under the Listing Rules. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as disposals of subsidiaries.
2013-06-04 English
Monthly return of equity issuer on movements in securities for the month ended 31 May 2013
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/05/2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange requirements. The document is not an annual or quarterly report, earnings release, or management discussion. It is a regulatory announcement about share capital changes and movements, fitting best under the category of Regulatory Filings (RNS).
2013-06-04 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.